PF-15648 |
COMTREX POTENCIA MAXIMA tabletas recubiertas |
2010-06-26 |
|
Novartis Consumer Health, Inc. |
Estados Unidos de América
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-23344 |
ZERIT 40 mg capsulas |
2010-10-18 |
|
Bristol Myers Squibb Company |
Puerto Rico, Estados Unidos
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37302 |
AMIKIN 250 mg/2 mL solución inyectable |
2011-04-27 |
|
Bristol Myers Squibb Ecuador Cia. Ltda. |
Ecuador
|
Agencias J. I. Cohen |
Americana S.A. |
Amicelco |
Bodega Farmacéutica S.A. |
Medicin Farmaceutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37589 |
DURACEF 500 mg Capsula |
2011-06-13 |
|
Bristol Myers Squibb Ecuador Cia. Ltda. |
Ecuador
|
Americana S.A. |
Amicelco |
Bodega Farmacéutica S.A. |
Agencias J.i. Cohen |
Medicin Farmaceutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37626 |
DURACEF 250 mg/5 mL Polvo para suspension oral |
2011-06-20 |
|
Bristol Myers Squibb Ecuador Cia. Ltda. |
Ecuador
|
Agencias J. I. Cohen |
Americana S.A. |
Amicelco |
Bodega Farmacéutica S.A. |
Medicin Farmaceutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37667 |
DURACEF 125 mg/5mL Polvo para suspension oral. |
2011-06-28 |
|
Bristol Myers Squibb Ecuador Cia. Ltda. |
Ecuador
|
Agencias J. I. Cohen |
Americana S.A. |
Amicelco |
Bodega Farmacéutica S.A. |
Medicin Farmaceutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-20088 |
TEMPRA 300 mg supositorios |
2008-08-12 |
|
Bristol Myers Squibb Ecuador Cia. Ltda. |
Ecuador
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-25777 |
MAXIPIME 1 g. Polvo para uso parenteral |
2010-12-26 |
|
Bristol Myers Squibb Ecuador Cia. Ltda. |
Ecuador
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-25852 |
MAXIPIME 500 mg. Polvo para uso parenteral. |
2006-03-19 |
|
Bristol Myers Squibb De Guatemala Ltda. |
Ecuador
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-23894 |
TRI-VI-FLUOR Gotas Solución oral |
2011-02-21 |
|
Bristol Myers Squibb Ecuador Cia. Ltda. |
Ecuador
|
Bodega Farmacéutica, S.A. |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|